E-therapeutics Share Discussion Threads

[1347] 11/4/2024 17:43

What benefits? You mean funding Directors lifestyles for a few more years as most in the UK have worked these companies out now? Yes there are too many con merchants and more chaff than wheat.

[takeiteasy] 11/4/2024 17:20

Moving to nasdaq saved the day for SLN with a wide variety of knowledgeable biotech start up investors to choose from. MCAP much higher in total now (many shares issued) - last fund raising significantly over subscribed. CEO here used to work at SLN and watches all this and yearns for NASDAQ listing for reaching the same benefits.

[ali47fish] 11/4/2024 17:17

millepede- are you referring to the ceo-please may i ask if you are invested in tex and if so what will you do- i ask because i am completetel disheartened and i still dont know wether i should sell or wait for the meeting as they need 75pc of the votes. suppose they dont get them what do think will happen

[the millipede] 11/4/2024 16:18

I genuinely think his narrative is misguided. London won’t fund this kind of company - with little revenue and a lot of hope - because we have spent years doing so and not making any money.

I have been investing on AIM on and off since 2008. Speculative pharma is the same as speculative oil. Risky and capital intensive. And, over the years, high risk has turned out to mean no reward.

Too many con artists, failed ventures, and investors with swingeing capital losses. New York will likely discover the same soon enough IMO.

[the millipede] 11/4/2024 14:52

Worth looking into the history of Silence Therapeutics, a previous firm run by Mortazavi. It delisted from AIM in 2021 and moved to Nasdaq.

Currently the Nasdaq share price is lower than the price was on last day of AIM dealing.

[gnnmartin] 11/4/2024 13:07

When a share is delisted, the company usually arranges with a broker to enable trade of matched bargains. However, I don't think that is mandated, and anyhow it is a poor substitute for trading a listed share. That said, I've never actually used such a facility, so my criticism may be misplaced.

[ali47fish] 11/4/2024 12:33

i understand that shares which are delisted cannot be traded- please explain if you know how going private with them works?

[ali47fish] 11/4/2024 08:35

is there any alternative to selling any one

[ali47fish] 10/4/2024 12:48

has anybody read the rns today- great dilemmas as to what to do for investments in isa if cancellation of aim is successfully voted on!

[jpuff] 10/4/2024 08:44

Hmm good for the longer term perhaps but obviously not today it would seem

[ali47fish] 10/4/2024 08:31

i see nobody is commenting- heavy fall

[ali47fish] 10/4/2024 07:01

important news delisting from aim/ nasdaq move

[ali47fish] 05/4/2024 16:26

Lombard odier increases holding from c 10 to 11 pc

[ali47fish] 15/3/2024 08:12

back to being volatile - hungry for news

[ali47fish] 07/2/2024 09:16

mac dont understand your english simplify please

[maccamcd] 07/2/2024 09:03

One eejit hitting them out around the traps. I've bought more

[ali47fish] 07/2/2024 08:44

bloody 12pc down no news what on earh is happening

[ali47fish] 31/1/2024 13:25

lewis good find

[dplewis1] 31/1/2024 13:12

Similar line of work to ETX -https://techfundingnews.com/5-things-to-know-about-cambridges-nuclera-eyeing-a-new-york-ipo-and-unicorn-status/

[ali47fish] 16/1/2024 08:08

dplewis-good on you

[dplewis1] 16/1/2024 07:09

Very nice update here, hitting milestones with partners etc